Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

Today, Johnson & Johnson MedTech, a leader in neurovascular care, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the TRUFILL n‑BCA Liquid Embolic ...
Medical Device and Diagnostic Industry (MD+DI)

FDA Expands Indication of TRUFILL n‑BCA Liquid Embolic System

J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.
Endovascular Today

J&J’s TruFill n-BCA Liquid Embolic System Approved to Treat Symptomatic Chronic Subdural Hematoma

Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...
MassDevice

Medtronic, J&J MedTech both get FDA nods for liquid embolic systems

Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) have both announced recent regulatory milestones for liquid embolic ...

Jury awards $27 million in malpractice suit against Holmes Regional

Jury awards $27 million in malpractice suit against Holmes Regional Medical Center after surgical procedure leaves man ...

Dog Spent Two Years Living in Landfill, Tears at Reaction To Being Rescued

DeSoto was left for dead in an area of landfill. Though he survived abandonment, his rescue came in the nick of time.